MMP9 and triple-A syndrome: Another study reported that simvastatin prevented the AngII-induced AAA formation in ApoE−/− mice by inhibiting MMP-2 and MMP-9 activity, MCP-1 protein expression, and ERK activity, indicating that inflammatory response and MAPK activation are involved in the pathogenesis of AAA [5].